Andrew is currently vice president and head of Collaborations in Data & Computational Sciences ast GSK. Andrew trained as a statistician at the University of Oxford although he has spent most of his career to date working as an epidemiologist. He started his professional career in infectious disease epidemiology, before spending a significant amount of time in oncology working at Cancer Research UK’s Epidemisology Unit in Oxford. He moved to industry in 2009 and held various roles first at Amgen and then latterly at GSK where he was most recently Global Head of Epidemiology and RWE. Andrew is an internationally renowned expert in epidemiological research and the intersection with health informatics leading to his interest in utilising routine data for research purposes. Andrew participates on several expert advisory boards where his expertise in epidemiological methods and health informatics are highly regarded.